Efrat Luttwak

Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

Yaël C. Cohen, Mor Zada, Shuang-Yin Wang et al. · Nature Medicine · 2021 · 246 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma

Chava Perry, Efrat Luttwak, R. Balaban et al. · Blood Advances · 2021 · 170 citations · Full text

Veterinary Medicine, Immunology, Oncology +13

Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma

Irit Avivi, Roi Balaban, Tamir Shragai et al. · British Journal of Haematology · 2021 · 77 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

[18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies

Dan Cohen, Efrat Luttwak, Ofrat Beyar‐Katz et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 58 citations

Medicine, Nuclear Medicine, Oncology +14

Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study

Tamir Shragai, Hila Magen, Noa Lavi et al. · British Journal of Haematology · 2022 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16